GRIA2 and Creutzfeldt Jacob disease: It is possible that GluA2 and PrP interact transiently in the ER, and the CJD and PG14 mutants retain GluA2 subunits because their exit from this organelle is delayed [19], whereas FFI PrP, which transits the ER more efficiently, has a milder effect.